Merck KGaA Tightens Focus With Allergopharma Sale
Allergens Business Acquired By Dermapharm For Undisclosed Sum
Germany’s family-controlled big pharma, Merck KGaA, is divesting its allergens business, Allergopharma to the fast-growing Munich healthcare company, Dermapharm Holding.
